The latest article from the National Prescribing Centre (click here to read the full article).
The NPC's article has a nice 'Action' section, which reports:
"Healthcare professionals should continue to follow NICE guidance on type 2 diabetes and agree individual HbA1c targets taking into account patient preference, and the balance of likely benefits and burden of treatment. A “keep it simple and safe” approach seems appropriate for the initial management of blood glucose in people with type 2 diabetes, whether aiming for macrovascular or microvascular prevention."
For those of you who are fans of the NPC, you may be interested to hear that they're being subsumed by NICE.
No comments:
Post a Comment